EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effect of Probiotics on the Symptomatology of Autism Spectrum Disorder and/or Attention Deficit/Hyperactivity Disorder in Children and Adolescents: Pilot Study

Meritxell Rojo-Marticella iD, Victoria Arija iD, Josefa Canals-Sans iD

Research on Child and Adolescent Psychopathology · 2025-02 · 53 (2) · 163-178

DOI: 10.1007/s10802-024-01278-7 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Research on Child and Adolescent Psychopathology, online erschienen am 11.01.2025. Verfasst von Meritxell Rojo-Marticella und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Mental Health Research Group (NUTRISAM), Universitat Rovira I Virgili (URV), Carretera de Valls, S/N, 43007, Tarragona, Spain. Hauptthemen laut MEDLINE: Probiotics, Attention Deficit Disorder with Hyperactivity, Autism Spectrum Disorder. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Universitat Rovira i Virgili's Martí Franqués Grant, Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ERDF), The Universitat Rovira i Virgili’s Martí Franqués Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study is to investigate the impact of using probiotics with strains related to dopamine and gamma-aminobutyric acid production on clinical features of autism spectrum disorder (ASD) and/or attention deficit/hyperactivity disorder (ADHD). This randomized, controlled trial involved 38 children with ADHD and 42 children with ASD, aged 5–16 years, who received probiotics ( Lactiplantibacillus plantarum and Levilactobacillus brevis 109/cfu/daily) or placebo for 12 weeks. Parent-reported symptoms were assessed using Conners' 3rd-Ed and the Social Responsiveness Scale Test, 2nd-Ed (SRS-2), and children completed the Conners Continuous Performance Test, 3rd-Ed (CPT 3) or Conners Kiddie CPT, 2nd-Ed (K-CPT 2). Executive functions, quality of life and sleep patterns were also parent-assessed. Intention-to-treat analyses, controlling for sociodemographic and nutritional covariates, revealed no significant inter-group differences in parent-reported or neuropsychological data after the probiotic intervention. However, age-stratified analyses showed improved hyperactivity-impulsivity symptoms in younger children with ASD (Cohen’s d = 1.245) and ADHD (Cohen’s d = 0.692). Intra-group analyses supported these findings in the aforementioned age and intervention group for both diagnoses. An improvement in impulsivity for children with ASD was also observed in the intra-group analysis of the CPT commissions scores (probiotic: p = 0.001, Cohen’s d = -1.216; placebo: p = 0.013, Cohen’s d = -0.721). A better comfort score (quality of life) was shown in children with ASD (probiotic: p = 0.010, Cohen’s d = 0.722; placebo: p = 0.099, Cohen’s d = 0.456). The probiotics used, may improve hyperactivity-impulsivity in children with ASD or/and ADHD and quality of life in children with ASD. Further research is warranted to explore probiotics as an adjunctive therapeutic intervention for NDs. Trial registration: clinicaltrials.gov Identifier: NCT05167110.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsAttention Deficit Disorder with HyperactivityAutism Spectrum DisorderHumansChildMaleFemaleAdolescentPilot ProjectsChild, PreschoolQuality of LifeExecutive FunctionTreatment Outcome

Stichwörter der Autor:innen

AdolescentsAttention deficit/hyperactive disorderAutism spectrum disorderChildrenProbioticsRandomized controlled trials

Autor:innen und Institutionen

  • Nutrition and Mental Health Research Group (NUTRISAM), Universitat Rovira I Virgili (URV), Carretera de Valls, S/N, 43007, Tarragona, Spain.
  • Department of Psychology, Research Center for Behavioral Assessment (CRAMC), Universitat Rovira I Virgili (URV), Tarragona, Spain.
  • Pere Virgili Institute for Health Research (IISPV), Universitat Rovira I Virgili (URV), Reus, Spain.
  • Nutrition and Mental Health Research Group (NUTRISAM), Universitat Rovira I Virgili (URV), Carretera de Valls, S/N, 43007, Tarragona, Spain. josefa.canals@urv.cat.
  • Department of Psychology, Research Center for Behavioral Assessment (CRAMC), Universitat Rovira I Virgili (URV), Tarragona, Spain. josefa.canals@urv.cat.
  • Pere Virgili Institute for Health Research (IISPV), Universitat Rovira I Virgili (URV), Reus, Spain. josefa.canals@urv.cat.

ORCID-Profile: Meritxell Rojo-Marticella, Victoria Arija, Josefa Canals-Sans

Förderung

  • The Universitat Rovira i Virgili's Martí Franqués Grant
  • Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund (ERDF)
  • The Universitat Rovira i Virgili’s Martí Franqués Grant
  • Universitat Rovira i Virgili

Zitieren

APA

Rojo-Marticella, M., Arija, V., & Canals-Sans, J. (2025). Effect of Probiotics on the Symptomatology of Autism Spectrum Disorder and/or Attention Deficit/Hyperactivity Disorder in Children and Adolescents: Pilot Study. Research on Child and Adolescent Psychopathology, 53(2), 163-178. https://doi.org/10.1007/s10802-024-01278-7

Vancouver

Rojo-Marticella M, Arija V, Canals-Sans J. Effect of Probiotics on the Symptomatology of Autism Spectrum Disorder and/or Attention Deficit/Hyperactivity Disorder in Children and Adolescents: Pilot Study. Research on Child and Adolescent Psychopathology. 2025;53(2):163-178. doi:10.1007/s10802-024-01278-7

BibTeX
@article{RojoMarticella2025,
  author = {Rojo-Marticella, Meritxell and Arija, Victoria and Canals-Sans, Josefa},
  title = {Effect of Probiotics on the Symptomatology of Autism Spectrum Disorder and/or Attention Deficit/Hyperactivity Disorder in Children and Adolescents: Pilot Study},
  journal = {Research on Child and Adolescent Psychopathology},
  year = {2025},
  volume = {53},
  number = {2},
  pages = {163--178},
  doi = {10.1007/s10802-024-01278-7}
}
Kostenlos starten →